Effect of esketamine adjunct to propofol in male patients undergoing rigid cystoscopic ureteral stent removal
Phase 4
- Conditions
- Urolithiasis
- Registration Number
- ChiCTR2400088880
- Lead Sponsor
- The First People's Hospital Of Hangzhou Lin'an District
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- Male
- Target Recruitment
- Not specified
Inclusion Criteria
(1)Male patients, aged 18 to 65 years, BMI 18-28 kg/m2<br>(2)ASA physical status I–II<br>(3)scheduled for rigid cystoscopic ureteral stent removal
Exclusion Criteria
(1) abnormal urinary tract anatomy; <br>(2) unstable heart diseases; <br>(3) hyperthyroidism; <br>(4) central nervous system diseases; <br>(5) neuropsychiatric disorders or drug abuse; <br>(6) allergic to the study drugs; <br>(7) ocular hypertension.
Study & Design
- Study Type
- Interventional study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Incidence of intraoperative hypoxemia;
- Secondary Outcome Measures
Name Time Method total propofol dosage;Incidence of adverse events;